Overview
I specialize in pelvic resection and reconstructive surgery. I have a special interest in researching and understanding how people’s gait is affected by pelvic surgery, and how we can improve reconstructive techniques in order to optimally balance restoration of anatomy and function.
My translational research is focused on understanding what drives disease progression and treatment resistance in sarcoma. Currently my focus is in chondrosarcoma, a subtype of bone sarcoma that produces cartilage, and has extremely limited treatment options beyond surgery. My lab is working to uncover the cellular derangements and immune interactions that allow these cells to metastasize, and develop targeted systemic therapies to improve patient outcomes.
Current Appointments & Affiliations
Assistant Professor of Orthopaedic Surgery
·
2021 - Present
Orthopaedic Surgery,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2019 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Financial Toxicity among Survivors of Extremity and Pelvic Sarcoma: A Retrospective Study.
Journal Article Ann Surg Oncol · March 2026 BACKGROUND: Financial toxicity in oncology, defined as the economic burden and psychosocial distress of cancer care, has been associated with poor clinical outcomes. Despite high projected treatment costs, data on financial toxicity in patients with sarcom ... Full text Link to item CiteASO Visual Abstract: Financial Toxicity among Survivors of Extremity and Pelvic Sarcoma: A Retrospective Study.
Journal Article Ann Surg Oncol · March 2026 Full text Link to item CiteThe Association Between Perioperative Denosumab and Local Recurrence After Surgical Management of Giant Cell Tumors: A Meta-Analysis.
Journal Article J Bone Joint Surg Am · February 9, 2026 BACKGROUND: Several studies have assessed the impact of perioperative denosumab on local recurrence (LR) after surgical management of giant cell tumor (GCT), with conflicting results. This meta-analysis evaluates the association between LR in patients unde ... Full text Link to item CiteRecent Grants
Defining and targeting CIC::DUX4-dependent survival in fusion-positive sarcomas
FellowshipCollaborator · Awarded by National Institutes of Health · 2025 - 2028Investigating drivers and therapeutic approaches for LCP1 overexpression in chondrosarcoma
ResearchPrincipal Investigator · Awarded by The Musculoskeletal Tumor Society · 2024 - 2026Fresh Tissue Lab
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Onkos Surgical, Inc · 2025 - 2025View All Grants
Education, Training & Certifications
Johns Hopkins University, School of Medicine ·
2012
M.D.